
### [MONDO:0005232](http://purl.obolibrary.org/obo/MONDO_0005232)
**Label:** large cell carcinoma

**Subclasses:** [MONDO:0003128](http://purl.obolibrary.org/obo/MONDO_0003128) (classic pulmonary blastoma), [MONDO:0003129](http://purl.obolibrary.org/obo/MONDO_0003129) (epithelial predominant pulmonary blastoma), [MONDO:0003047](http://purl.obolibrary.org/obo/MONDO_0003047) (thymus large cell carcinoma), [MONDO:0004237](http://purl.obolibrary.org/obo/MONDO_0004237) (large cell carcinoma with rhabdoid phenotype), [MONDO:0006138](http://purl.obolibrary.org/obo/MONDO_0006138) (cervical large cell neuroendocrine carcinoma), [MONDO:0003049](http://purl.obolibrary.org/obo/MONDO_0003049) (ovarian large-cell neuroendocrine carcinoma), [MONDO:0003960](http://purl.obolibrary.org/obo/MONDO_0003960) (pulmonary large cell neuroendocrine carcinoma), [MONDO:0006279](http://purl.obolibrary.org/obo/MONDO_0006279) (lung sarcomatoid carcinoma), [MONDO:0006275](http://purl.obolibrary.org/obo/MONDO_0006275) (lung giant cell carcinoma), [MONDO:0011014](http://purl.obolibrary.org/obo/MONDO_0011014) (pleuropulmonary blastoma), [MONDO:0017288](http://purl.obolibrary.org/obo/MONDO_0017288) (dicer1 syndrome), [MONDO:0017289](http://purl.obolibrary.org/obo/MONDO_0017289) (fetal lung interstitial tumor), [MONDO:0003959](http://purl.obolibrary.org/obo/MONDO_0003959) (breast large cell neuroendocrine carcinoma), [MONDO:0020555](http://purl.obolibrary.org/obo/MONDO_0020555) (pleuropulmonary blastoma type 1), [MONDO:0020556](http://purl.obolibrary.org/obo/MONDO_0020556) (pleuropulmonary blastoma type 2), [MONDO:0020557](http://purl.obolibrary.org/obo/MONDO_0020557) (pleuropulmonary blastoma type 3), [MONDO:0005933](http://purl.obolibrary.org/obo/MONDO_0005933) (pulmonary blastoma), [MONDO:0004128](http://purl.obolibrary.org/obo/MONDO_0004128) (lung occult large cell carcinoma), [MONDO:0006404](http://purl.obolibrary.org/obo/MONDO_0006404) (salivary gland large cell carcinoma), [MONDO:0006347](http://purl.obolibrary.org/obo/MONDO_0006347) (pancreatic large cell neuroendocrine carcinoma), [MONDO:0006468](http://purl.obolibrary.org/obo/MONDO_0006468) (thyroid gland undifferentiated (anaplastic) carcinoma), [MONDO:0005057](http://purl.obolibrary.org/obo/MONDO_0005057) (large cell neuroendocrine carcinoma), [MONDO:0004142](http://purl.obolibrary.org/obo/MONDO_0004142) (lung combined large cell neuroendocrine carcinoma), [MONDO:0003050](http://purl.obolibrary.org/obo/MONDO_0003050) (lung large cell carcinoma), [MONDO:0006283](http://purl.obolibrary.org/obo/MONDO_0006283) (lymphoepithelioma-like lung carcinoma), 

**Mapped go classes:** [GO:0035068](http://purl.obolibrary.org/obo/GO_0035068) (micro-ribonucleoprotein complex), [GO:0004386](http://purl.obolibrary.org/obo/GO_0004386) (helicase activity), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0004519](http://purl.obolibrary.org/obo/GO_0004519) (endonuclease activity), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:0016891](http://purl.obolibrary.org/obo/GO_0016891) (endoribonuclease activity, producing 5'-phosphomonoesters), [GO:0070883](http://purl.obolibrary.org/obo/GO_0070883) (pre-miRNA binding), [GO:0030422](http://purl.obolibrary.org/obo/GO_0030422) (production of siRNA involved in RNA interference), [GO:0035279](http://purl.obolibrary.org/obo/GO_0035279) (mRNA cleavage involved in gene silencing by miRNA), [GO:0030423](http://purl.obolibrary.org/obo/GO_0030423) (targeting of mRNA for destruction involved in RNA interference), [GO:0031054](http://purl.obolibrary.org/obo/GO_0031054) (pre-miRNA processing), [GO:0035195](http://purl.obolibrary.org/obo/GO_0035195) (gene silencing by miRNA), [GO:0035196](http://purl.obolibrary.org/obo/GO_0035196) (production of miRNAs involved in gene silencing by miRNA), [GO:0006396](http://purl.obolibrary.org/obo/GO_0006396) (RNA processing), [GO:0004530](http://purl.obolibrary.org/obo/GO_0004530) (deoxyribonuclease I activity), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0004525](http://purl.obolibrary.org/obo/GO_0004525) (ribonuclease III activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0006309](http://purl.obolibrary.org/obo/GO_0006309) (apoptotic DNA fragmentation), [GO:0031047](http://purl.obolibrary.org/obo/GO_0031047) (gene silencing by RNA), [GO:0070578](http://purl.obolibrary.org/obo/GO_0070578) (RISC-loading complex), [GO:0016442](http://purl.obolibrary.org/obo/GO_0016442) (RISC complex), [GO:0050767](http://purl.obolibrary.org/obo/GO_0050767) (regulation of neurogenesis), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0098795](http://purl.obolibrary.org/obo/GO_0098795) (mRNA cleavage involved in gene silencing) 54.17%
- [GO:0070918](http://purl.obolibrary.org/obo/GO_0070918) (production of small RNA involved in gene silencing by RNA) 54.17%
- [GO:0070578](http://purl.obolibrary.org/obo/GO_0070578) (RISC-loading complex) 54.17%
- [GO:0035279](http://purl.obolibrary.org/obo/GO_0035279) (mRNA cleavage involved in gene silencing by miRNA) 54.17%
- [GO:0035196](http://purl.obolibrary.org/obo/GO_0035196) (production of miRNAs involved in gene silencing by miRNA) 54.17%
- [GO:0035195](http://purl.obolibrary.org/obo/GO_0035195) (gene silencing by miRNA) 54.17%
- [GO:0035194](http://purl.obolibrary.org/obo/GO_0035194) (posttranscriptional gene silencing by RNA) 54.17%
- [GO:0035068](http://purl.obolibrary.org/obo/GO_0035068) (micro-ribonucleoprotein complex) 54.17%
- [GO:0031332](http://purl.obolibrary.org/obo/GO_0031332) (RNAi effector complex) 54.17%
- [GO:0031054](http://purl.obolibrary.org/obo/GO_0031054) (pre-miRNA processing) 54.17%
- [GO:0031050](http://purl.obolibrary.org/obo/GO_0031050) (dsRNA fragmentation) 54.17%
- [GO:0031047](http://purl.obolibrary.org/obo/GO_0031047) (gene silencing by RNA) 54.17%
- [GO:0030423](http://purl.obolibrary.org/obo/GO_0030423) (targeting of mRNA for destruction involved in RNA interference) 54.17%
- [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development) 54.17%
- [GO:0016442](http://purl.obolibrary.org/obo/GO_0016442) (RISC complex) 54.17%


